Interchangeability of generic anti-epileptic drugs: a quantitative analysis of topiramate and gabapentin (Q83868645)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Interchangeability of generic anti-epileptic drugs: a quantitative analysis of topiramate and gabapentin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Marc Maliepaard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Nikola Banishki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Christine C Gispen-de Wied

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Steven Teerenstra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

André J Elferink

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

15 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1007-1016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration

28 January 2020

cites work

1 reference

12 December 2020

Bioequivalence of antiepileptic drugs: how close is close enough?

1 reference

12 December 2020

Generics: what is the role of registration authorities

1 reference

12 December 2020

The transitivity of bioequivalence testing: potential for drift

1 reference

12 December 2020

Requirements for generic anti-epileptic medicines: a regulatory perspective

1 reference

12 December 2020

What's the problem with generic antiepileptic drugs?: a call to action

1 reference

12 December 2020

Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes

1 reference

12 December 2020

Experience with generic drugs in epilepsy patients: an electronic survey of members of the German, Austrian and Swiss branches of the ILAE

1 reference

12 December 2020

Lower phenytoin serum levels in persons switched from brand to generic phenytoin

1 reference

12 December 2020

Therapeutic equivalency of generic antiepileptic drugs: results of a survey

1 reference

12 December 2020

Guidelines for Epidemiologic Studies on Epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy

1 reference

12 December 2020

A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma

1 reference

12 December 2020

For and against generic prescribing

1 reference

12 December 2020

Is generic prescribing acceptable in epilepsy?

1 reference

12 December 2020

Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes

1 reference

12 December 2020

Current approaches to the use of generic antiepileptic drugs

1 reference

12 December 2020

Are there potential problems with generic substitution of antiepileptic drugs? A review of issues

1 reference

12 December 2020

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

1 reference

12 December 2020

Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy

1 reference

12 December 2020

Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures

1 reference

12 December 2020

Antiepileptic drugs: generic versus branded treatments

1 reference

12 December 2020

Pharmacy and generic substitution of antiepileptic drugs: missing in action?

1 reference

12 December 2020

10.1007/S00228-011-1041-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494766%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference